Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms.
about
A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer.Diagnosis and management of pancreatic cancer.Multimodality therapy offers a chance for cure in patients with pancreatic adenocarcinoma deemed unresectable at first operative explorationNeoadjuvant strategies for pancreatic cancerClinical evaluation, imaging studies, indications for cytologic study and preprocedural requirements for duct brushing studies and pancreatic fine-needle aspiration: The Papanicolaou Society of Cytopathology Guidelines.Pancreatic adenocarcinomaLaparoscopy in the staging of pancreatic cancer.Inferior mesenteric vein serves as an alternative guide for transection of the pancreatic body during pancreaticoduodenectomy with concomitant vascular resection: a comparative study evaluating perioperative outcomes.Multidetector CT of pancreatic adenocarcinoma: diagnostic advances and therapeutic relevance.Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas.Diagnosis, Preoperative Evaluation, and Assessment of Resectability of Pancreatic and Periampullary CancerLiver blood supply after a modified Appleby procedure in classical and aberrant arterial anatomyWell-differentiated pancreatic nonfunctioning tumors/carcinoma.Controversies in the management of borderline resectable proximal pancreatic adenocarcinoma with vascular involvement.Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines.Clinical evaluation, imaging studies, indications for cytologic study, and preprocedural requirements for duct brushing studies and pancreatic FNA: the Papanicolaou Society of Cytopathology recommendations for pancreatic and biliary cytology.Efficacy of Neoadjuvant Versus Adjuvant Therapy for Resectable Pancreatic Adenocarcinoma: A Decision Analysis.Diagnostic workup of patients with suspected pancreatic carcinoma: the University of California-Los Angeles approach.The role of chemoradiation therapy in locally advanced pancreatic cancer.Translational advances and novel therapies for pancreatic ductal adenocarcinoma: hope or hype?Phase II trial of primary radiation therapy and concurrent chemotherapy for patients with locally advanced pancreatic cancer.Laparoscopic evaluation in pancreatic cancer.Non-metastatic Pancreatic Cancer: Resectable, Borderline Resectable, and Locally Advanced-Definitions of Increasing Importance for the Optimal Delivery of Multimodality Therapy.Additional support for neoadjuvant therapy in the management of pancreatic cancer.Pancreaticoduodenectomy after downstaging of pancreatic carcinoma by chemotherapy.
P2860
Q33408075-289A3198-857B-49D7-BC6C-85F08AA65C42Q33759924-6D48939D-0527-4DDA-8679-89A39E3484B5Q33860986-5EFA2005-29CA-4F23-A483-1F7FB9435838Q33948343-AADED8BC-E7DE-4977-A523-54942AFAE47BQ34127295-EF775A76-BEC6-43F5-BFFB-0F2A2F02D1F9Q34140498-BC340420-D7D7-408B-8B92-7479094FC6CCQ34190493-24573202-43E2-4CC8-AF0F-5CDD1C5F3987Q34544291-66CFED39-0937-4FE3-AB78-95CC2626A22DQ35159838-89649328-B582-48C2-BC93-2DF80452053DQ35790591-622B4026-8C43-48A8-8CD2-C8F548EA974CQ36400041-8FF2C116-8517-44F5-8F9B-61876BCB9875Q36736768-140D1197-2617-4065-B70B-7FCF587983C3Q36741127-EE953D1B-C124-424C-BE3B-35578E6E319AQ37124979-2E85DF16-D4FD-441B-BAB4-72BACFC7AFB6Q37252144-76CD5B70-E04A-4B9D-AEAF-BFF5DA9AD81BQ38189751-F4A95A31-86C6-4A93-ADB3-E2C557BEDCB9Q40760990-77708B4D-EC2A-400D-BB59-FCDB04209B2BQ41453581-E1342A6E-90B3-4F80-86D2-D81D58A863D5Q41842364-8B02C36F-A77D-4767-8D29-1158E66D884EQ42698235-DDDF61DA-2BBC-40AB-8D25-C5261AEAAA8AQ46601912-A0E2A78D-D3A2-4BF9-81C3-5FA992B06F73Q52234211-37D85221-9649-4820-92CD-1B15355B600EQ53000025-1FCEA364-76FC-43FF-8F88-A0F3C02232D6Q53665459-133561DF-FE8E-42A4-80A3-6A0B1EBCBEF7Q54976122-CE0C3726-21B6-4976-9A7C-4B9D1260DC0E
P2860
Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms.
description
1994 nî lūn-bûn
@nan
1994 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Thin-section contrast-enhanced ...... alignant pancreatic neoplasms.
@ast
Thin-section contrast-enhanced ...... alignant pancreatic neoplasms.
@en
Thin-section contrast-enhanced ...... alignant pancreatic neoplasms.
@nl
type
label
Thin-section contrast-enhanced ...... alignant pancreatic neoplasms.
@ast
Thin-section contrast-enhanced ...... alignant pancreatic neoplasms.
@en
Thin-section contrast-enhanced ...... alignant pancreatic neoplasms.
@nl
prefLabel
Thin-section contrast-enhanced ...... alignant pancreatic neoplasms.
@ast
Thin-section contrast-enhanced ...... alignant pancreatic neoplasms.
@en
Thin-section contrast-enhanced ...... alignant pancreatic neoplasms.
@nl
P2093
P1476
Thin-section contrast-enhanced ...... alignant pancreatic neoplasms.
@en
P2093
Abbruzzese JL
Charnsangavej C
Fenoglio CJ
Fuhrman GM
P304
104-11; discussion 111-3
P356
10.1016/0002-9610(94)90060-4
P407
P577
1994-01-01T00:00:00Z